Published: 6 April 2016
Author(s): Jacopo Azzollini, Giulietta Scuvera, Eleonora Bruno, Patrizia Pasanisi, Daniela Zaffaroni, Mariarosaria Calvello, Barbara Pasini, Carla B. Ripamonti, Mara Colombo, Valeria Pensotti, Paolo Radice, Bernard Peissel, Siranoush Manoukian
Issue: April 2016
Section: Original Article

BRCA mutation screening is frequently offered on the basis of the fulfillment of empirical selection criteria, thought to be indicative of a genetic predisposition to breast/ovarian cancer (BrCa/OvCa). This study aimed to evaluate, in a large cohort of BrCa/OvCa families, the mutation detection rate (DR) associated with specific clinical features and the relative performance of the employed selection criteria.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.